Molecular Cytogenetics Market Future Innovation Ways, Growth & Profit Analysis, Forecast By 2032
The global Molecular Cytogenetics Market is anticipated to be valued US$ 2,761.9 million in 2022, with a CAGR of 8.9% from 2022 to 2032. The advancement is ascribed to improving illness diagnosis methodologies, increased public knowledge of viral diseases, and rising amounts of government support in various jurisdictions. From 2016 to 2021, the enterprise key management market grew at a CAGR of 10.3%.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2031
Molecular cytogenetics comprises of molecular biology and cytogenetics.
Cytogenetics refers to the study of chromosomes and molecular cytogenetics
further involves the analysis of genetic variations or alterations through
in-situ hybridization techniques. Molecular cytogenetics finds crucial
applications in the fields of biology and medicine.
Molecular cytogenetics studies the structural and functional organization
of the chromosomes and its nucleus, genomic variations, expression and
evolution, chromosomal abnormalities, particularly in medicinal and
cancer-related genetics.
In molecular cytogenetics, techniques such as fluorescence in situ
hybridization (FISH) are conducted wherein DNA probes are labeled with
different colored fluorescent tags to visualize the whole genome or the most
specific regions of the genome. Also, the virtual karyotyping technique is done
in molecular cytogenetics to assess entire genome for the changes in the number
of copies of the genome. FISH & GISH are one of the most reliable
techniques for analyzing chromosomes.
Global Molecular Cytogenetics Market: Drivers and Restraints
Molecular cytogenetics provides a scan and analysis of the whole genome
organization, its structure and behavior at high resolutions and also the
visualization of single peculiar genomic loci which is a major growth driver
for the global molecular cytogenetics market. The recent advances in the fields
of molecular biology and cytogenetics have brought about several key
developments in the research of mitosis and meiosis processes, chromosome
structures and its subsequent manipulation, gene expression and its regulation,
and gene silencing techniques. Molecular cytogenetics is primarily driven by
cancer diagnostics which offers techniques for imaging in genetics,
epigenetics, and cytology and can be utilized for chromosomal modifications.
To learn more about this report: https://www.futuremarketinsights.com/reports/molecular-cytogenetics-market
Global Molecular Cytogenetics Market: Regional Outlook
Geographically, the global molecular cytogenetics market is segmented
into seven regions, namely North America, Latin America, Western Europe,
Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East
and Africa (MEA). North America & Western Europe are market leaders
regarding revenue in the global molecular cytogenetics market owing to the
presence of large number of clinical research laboratories and research &
academic institutes. Japan is the third major contributor to the global
molecular cytogenetics market mainly due to the well-established collaborations
between the manufacturers and research laboratories. Also, the role of
personalized medicine in treatment of genetic or other disorders is gaining
pace in the developed countries and this factor is anticipated to unfold novel
opportunities for the key players during the forecast period. APEJ is
anticipated to register healthy CAGR in the global molecular cytogenetics market
due to a surge in the number of scientific researches being undertaken in this
region. Middle East and Africa and Latin America are at nascent stages in the
global molecular cytogenetics market and are projected to register steady
growth rates during the forecast period.
Key Companies Profiled:
- Thermo Fisher
Scientific Inc.
- GeneDx
- CytoTest Inc.
- Empire Genomics
- Abbott
Laboratories
- Agilent
Technologies
- Biological
Industries
- PerkinElmer
Inc.
- Bio-RAD
Laboratories Inc.
- F. Hoffmann-La
Roche AG
Key Segments Profiled in the Molecular Cytogenetics Industry Survey
Global Molecular Cytogenetics Market by Technique Type:
- Genomic in Situ
Hybridization (GISH)
- Fluorescence in
Situ Hybridization (FISH)
- Multicolour
Fluorescence in Situ Hybridization
- Multiplex
Fluorescence in Situ Hybridization (M-FISH)
- Spectral
Karyotyping (SKY)
- Comparative
Genomic Hybridization (CGH)
- Array
Comparative Genomic Hybridization
- Other Molecular
Cytogenetic Techniques
Global Molecular Cytogenetics Market by Product Type:
- Instruments for
Molecular Cytogenetics
- Reagents &
Kits for Molecular Cytogenetics
Global Molecular Cytogenetics Market by End User:
- Molecular
Cytogenetics in Pharmaceutical & Biotechnology Companies
- Molecular
Cytogenetics in Clinical Research Laboratories
- Molecular
Cytogenetics in Research & Academic Institutes
- Molecular
Cytogenetics in Hospitals
- Molecular
Cytogenetics in Diagnostic Centers
Comments
Post a Comment